Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Angiotech's micellar paclitaxel enters clinic for arthritis

June 18, 1998

Topical antiinflammatory corticosteroid approved for marketing in Japan

June 17, 1998

Santen presents new LTA4 hydrolase inhibitors

June 15, 1998

Preparation and use of new MMP inhibitors from Warner-Lambert

June 12, 1998

Procter & Gamble reveals new series of metalloprotease inhibitors

June 12, 1998

Warner-Lambert team describes preferential inhibitors of MMP-2 and MMP-3

June 11, 1998

Procter & Gamble R&D on metalloprotease inhibition

June 9, 1998

Abbott and Boehringer Ingelheim sign comarketing agreement

June 9, 1998

Zimmer and Anika expand Orthovisc agreement

June 8, 1998

APHS: a selective COX-2 inhibitor for treating inflammatory and proliferative disorders

June 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...